Twist Bioscience’s New Customizable Panels to Advance Minimal Residual Disease Detection
Twist Bioscience launched a custom solution for NGS workflow, offering fully customizable panels to quickly detect minimal residual disease.
Read MorePosted by Andy Lundin | Jun 8, 2022 | Cancer |
Twist Bioscience launched a custom solution for NGS workflow, offering fully customizable panels to quickly detect minimal residual disease.
Read MorePosted by Chris Wolski | Jun 2, 2022 | Compliance |
As the bipartisan VALID Act moves closer to a vote, the potential regulation could impact the future of laboratory-developed tests (LDTs).
Read MorePosted by Andy Lundin | May 31, 2022 | Kidney Disease |
Researchers established the inherited condition, TULP3-related ciliopathy, which causes kidney and liver failure in children and adults.
Read MorePosted by Andy Lundin | May 30, 2022 | Immunoassay Reagents & test Kits |
Co-Diagnostics completed the principal design work of a PCR test for the monkeypox virus, which is exhibiting a multi-country outbreak.
Read MorePosted by Andy Lundin | May 25, 2022 | Miscellaneous |
AACC has urged the U.S. Senate HELP Committee not to include the VALID Act in its omnibus Food and Drug Administration user fee legislation.
Read More